Peer-reviewedCC BYFrontiers in ophthalmology
Activating transcription factor 6 is involved in the beneficial effects of growth hormone-releasing hormone antagonists in the corneal endothelium
- 1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe , , ,
Related
- Gonadotropin-releasing hormone antagonists versus agonists for endometriosis: a systematic review and meta-analysis of randomized controlled trials
- Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases
- Multi-scale analysis of histological, ultrastructural and proteomic regional differences in the Descemet’s membrane-endothelium of Fuchs endothelial corneal dystrophy
- Hysteroscopic polypectomy with vs. without levonorgestrel-releasing intrauterine system in women with endometrial polyps and dysmenorrhea
- Comparative Effectiveness of Hysteroscopic Endometrial Resection Versus the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding: A Retrospective Cohort Study
BibTeX
@article{sarker2026activating,
title = {{Activating transcription factor 6 is involved in the beneficial effects of growth hormone-releasing hormone antagonists in the corneal endothelium}},
author = {Md Matiur Rahman Sarker and Saikat Fakir and Madan Sigdel and Nektarios Barabutis},
journal = {Frontiers in ophthalmology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13661439},
note = {CC BY},
}
RIS
TY - JOUR
TI - Activating transcription factor 6 is involved in the beneficial effects of growth hormone-releasing hormone antagonists in the corneal endothelium
AU - Md Matiur Rahman Sarker
AU - Saikat Fakir
AU - Madan Sigdel
AU - Nektarios Barabutis
PY - 2026
DA - 2026/10/16
JO - Frontiers in ophthalmology
UR - https://europepmc.org/article/PMC/PMC13661439
SN - 2674-0826
ER -